Skip to search formSkip to main contentSkip to account menu

BMS 269223

Known as: BMS-269223, BMS269223 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

BenzofuransFactor Xa inhibitorsLactams

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitors.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)